Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
June 19, 2008
[Master files: less paper, more substance. Special rules for special medicines: Plasma Master File and Vaccine Antigen Master File]
Rainer Seitz, M Haase
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
June 26, 2010
Quality and Safety in Blood Supply in 2010
Rainer Seitz, Margarethe Heiden
Thrombosis Research
|
October 16, 2002
Quality of therapeutic plasma-requirements for marketing authorization
Margarethe Heiden, Rainer Seitz
Journal of Thrombosis and Haemostasis : JTH
|
November 24, 2020
Thromboinflammation in COVID-19: Can α<sub>2</sub> -macroglobulin help to control the fire?
Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
Biologicals : Journal of the International Association of Biological Standardization
|
June 26, 2024
COVID-19: A case for plasma derived natural anticoagulants?
Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
Analytical Biochemistry
|
April 25, 2013
Factor XIIIa generation assay: a tool for studying factor XIII function in plasma
Johannes Dodt, Peter Volkers, Rainer Seitz
Infection
|
February 17, 2025
Viral sepsis - pathophysiology and disease manifestation
Lutz G Gürtler, Wolfgang Schramm, Rainer Seitz
International Immunopharmacology
|
January 10, 2008
The hyaluronic acid-binding protease: a novel vascular and inflammatory mediator?
Michael Etscheid, Julia Kress, Rainer Seitz, et al.
Transfusion
|
December 17, 2009
Management of blood supplies during an influenza pandemic
Christel Kamp, Margarethe Heiden, Olaf Henseler, et al.
British Journal of Haematology
|
October 31, 2015
Free factor XIII activation peptide (fAP-FXIII) is a regulator of factor XIII activity via factor XIII-B
Johannes Dodt, Ralf Pasternack, Rainer Seitz, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
June 19, 2008
[Master files: less paper, more substance. Special rules for special medicines: Plasma Master File and Vaccine Antigen Master File]
Rainer Seitz, M Haase
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
June 26, 2010
Quality and Safety in Blood Supply in 2010
Rainer Seitz, Margarethe Heiden
Thrombosis Research
|
October 16, 2002
Quality of therapeutic plasma-requirements for marketing authorization
Margarethe Heiden, Rainer Seitz
Journal of Thrombosis and Haemostasis : JTH
|
November 24, 2020
Thromboinflammation in COVID-19: Can α<sub>2</sub> -macroglobulin help to control the fire?
Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
Biologicals : Journal of the International Association of Biological Standardization
|
June 26, 2024
COVID-19: A case for plasma derived natural anticoagulants?
Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
Analytical Biochemistry
|
April 25, 2013
Factor XIIIa generation assay: a tool for studying factor XIII function in plasma
Johannes Dodt, Peter Volkers, Rainer Seitz
Infection
|
February 17, 2025
Viral sepsis - pathophysiology and disease manifestation
Lutz G Gürtler, Wolfgang Schramm, Rainer Seitz
International Immunopharmacology
|
January 10, 2008
The hyaluronic acid-binding protease: a novel vascular and inflammatory mediator?
Michael Etscheid, Julia Kress, Rainer Seitz, et al.
Transfusion
|
December 17, 2009
Management of blood supplies during an influenza pandemic
Christel Kamp, Margarethe Heiden, Olaf Henseler, et al.
British Journal of Haematology
|
October 31, 2015
Free factor XIII activation peptide (fAP-FXIII) is a regulator of factor XIII activity via factor XIII-B
Johannes Dodt, Ralf Pasternack, Rainer Seitz, et al.
Page
of 4